Previous close | 11.48 |
Open | 11.36 |
Bid | 11.47 x 300000 |
Ask | 11.75 x 300000 |
Day's range | 11.36 - 11.36 |
52-week range | 10.21 - 15.02 |
Volume | |
Avg. volume | 54 |
Market cap | 9.937B |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | 40.59 |
EPS (TTM) | 0.28 |
Earnings date | 01 Aug 2024 |
Forward dividend & yield | 0.35 (3.06%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Medical device manufacturer’s policy ultimately passed, making maximum payout for Deepak Nath $11.8m
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip